Business / Finance

RSS

Camena Bioscience closes $10m Series A financing as demand for DNA synthesis technology increases

Camena Bioscience, a synthetic biology company providing genes to the pharmaceutical and biotechnology industries.

From Camena Bioscience 3 Jul 2023

ATCC announces new award from BARDA to further support its medical countermeasures clinical studies network

ATCC will serve as a centralized facility to support the storage and distribution of clinical samples and investigational products for BARDA.

From American Type Culture Collection (ATCC) 29 Jun 2023

Albumedix enters into collaboration agreement with Cell and Gene Therapy Catapult

Albumedix Ltd., an enabler of advanced therapies and the world leader in recombinant human albumin (rAlb), announced today that they have entered into a collaboration agreement with Cell and Gene Therapy Catapult (CGT Catapult) to investigate the use of Albumedix´ proprietary albumin-based solutions for advanced therapy applications, including viral vectors manufacturing.

From Albumedix Ltd. 29 Jun 2023

Albumedix and Valneva expand collaboration to include newly approved inactivated COVID-19 vaccine

Albumedix Ltd., a recognized global leader in Recombinant Human Albumin (rHA), specializing in the enablement of advanced therapies and biopharmaceuticals, today announces the expansion of its existing collaboration with Valneva SE, a specialty vaccine company focused on prevention of infectious diseases with significant unmet medical need.

From Albumedix Ltd. 29 Jun 2023

Researcher from Wageningen University wins Green CellDrop Giveaway

DeNovix Inc. is pleased to announce the winner of the Green CellDrop Automated Cell Counter Giveaway: Michiel Schrijen from Wageningen University, Netherlands! Selected at random from thousands of entries from scientists worldwide, the CellDrop will be housed in the Biosystematics Group at the university.

From DeNovix Inc. 29 Jun 2023

Mastering repeatability in cell culture with INTEGRA Biosciences’ WELLJET peristaltic pump dispenser

INTEGRA Biosciences’ WELLJET reagent dispenser and EasySnap™ dispensing cassettes offer a unique solution to common issues in cell-based workflows.

From INTEGRA Biosciences 27 Jun 2023

Berlin's senator for economic affairs, Franziska Giffey, and state secretary Michael Biel visit lab-tech company KNAUER

The management of KNAUER Wissenschaftliche Geräte GmbH, a well-known Berlin-based manufacturer of high-tech laboratory instruments.

From KNAUER Wissenschaftliche Geräte GmbH 26 Jun 2023

FUJIFILM Irvine Scientific offers expanded capabilities of Presagen’s Life Whisperer Platform to aid with clinical decision-making in IVF

Genetics AI-based software module added to provide objective scoring of embryo genetic integrity and likelihood of clinical pregnancy.

From FUJIFILM Irvine Scientific 24 Jun 2023

Leibniz-HKI and Analytik Jena develop facility for automated testing of drug candidates

A new robotics platform was inaugurated at the Leibniz Institute for Natural Product Research and Infection Biology (Leibniz-HKI) on Thursday, June 15, 2023, in the presence of Thuringia's State Secretary for Research, Innovation and Economic Development.

From Analytik Jena AG 23 Jun 2023

Introducing CELLER8®: Revolutionising Wellness with PEMF Technology

Med-tech manufacturer, Bedfont® Scientific Ltd., launches new CELLER8® PEMF device with exclusive distributor, NewMed Ltd. at the Health Optimisation Summit 2023.

From Bedfont® Scientific Ltd 22 Jun 2023

INTEGRA Biosciences’ pipettes help to advance cancer drug discovery

The Institute for Cancer Research (ICR), part of the University of London, is using VIAFLO electronic pipettes from INTEGRA Biosciences to streamline its preclinical drug screening and translational medicine workflows.

From INTEGRA Biosciences 20 Jun 2023

Closed Loop Medicine appoints Kate Woolland as Chief Operating Officer

The key executive appointment supports the strategic, operational delivery of the Company’s product and partnership programs.

From Closed Loop Medicine 20 Jun 2023

H.E.L Group expands into new purpose-designed facilities

Bespoke lab and office space designed to foster innovation and collaboration with colleagues and customers.

From H.E.L Group 20 Jun 2023

Sphere Fluidics’ Pico-Mine platform chosen by Biosyntia to accelerate synthetic biology and metabolic workflows

Platform selected to accelerate precision fermentation workflows, to support more sustainable and cost-effective manufacturing for active ingredients in vitamins and bioactive.

From Sphere Fluidics 20 Jun 2023

Catalent expands OneBio® suite for integrated development, manufacturing and supply across biologic modalities

Catalen today announced that it has expanded its integrated development, manufacturing and supply solution, OneBio® Suite, across a range of biologic modalities, including antibody and recombinant proteins, cell and gene therapies, and mRNA.

From Catalent 16 Jun 2023

Complete Genomics Announces Updated Mission and New Partnerships on 18th Anniversary

Complete Genomics, Inc., a pioneering genomics company, today unveiled updated mission/vision statement to reflect renewed ambitions in taking on more for a better world, in celebration of its 18th anniversary.

From MGI 15 Jun 2023

Cerillo showcases wireless, scalable, off-the-shelf co-culture solution

Cerillo, a biotechnology company at the forefront of developing advanced research platforms for the study of the microbiome, will host demonstrations of the company’s new co-culture duet system at ASM Microbe 2023 from June 16-18th in Houston, Texas at booth #704.

From Cerillo 15 Jun 2023

Charles River Laboratories Launches Off-the-Shelf Lentiviral Vector Packaging Plasmids

Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of its off-the-shelf lentiviral vector (LVV) packaging plasmids, providing a streamlined solution to the challenges associated with plasmid sourcing in cell and gene therapies.

From Charles River Laboratories, Inc. 13 Jun 2023

Axol Bioscience collaborates with StrataStem to deliver stem cell based ‘clinical trial in a dish’ for Alzheimer’s disease

Axol Bioscience Ltd. (Axol), a leading pluripotent stem cell technology provider for drug discovery has signed an exclusive agreement with StrataStem to access and commercialize its extensive collection of Alzheimer’s Disease (AD) patient samples.

From Axol Bioscience Ltd 7 Jun 2023

INTEGRA Biosciences’ pipettes help to combat prostate cancer

The lab is now in the process of moving these products over to prostate cancer screening, where they are helping to improve result accuracy and turnaround times and, ultimately, support timely diagnosis and treatment.

From INTEGRA Biosciences 6 Jun 2023